Skip to main content

MYELOMA KIDNEY

Tracking # 20-811431

$99999.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

MULTIPLE MYELOMA (MM) IS A PLASMA CELL DISORDER CHARACTERIZED BY CLONAL PROLIFERATION OF MALIGNANT PLASMA CELLS PRODUCING MONOCLONAL PROTEINS AND CAUSING ORGAN DAMAGE. THE INVOLVEMENT OF THE KIDNEY IN PLASMA CELL DYSCRASIAS INCLUDING MULTIPLE MYELOMA IS VERY COMMON. RENAL DISEASE IN PATIENTS WITH MULTIPLE MYELOMA IS SOMETIMES REFERRED TO AS MYELOMA KIDNEY. AT THE TIME OF PRESENTATION, ABOUT 50 PERCENT OF PATIENTS HAVE RENAL INVOLVEMENT. RENAL INVOLVEMENT IS ASSOCIATED WITH HIGHER MORTALITY. THIS ACTIVITY EXAMINES WHEN MYELOMA KIDNEY SHOULD BE CONSIDERED, HOW IT SHOULD BE MANAGED, AND THE ROLE OF INTERPROFESSIONAL TEAMS IN THE CARE OF PATIENTS WITH THIS CONDITION.

Subject areas

This course counts toward the state boards and subject areas below.

Bahamas Medical Council

Specialty Medical Practitioner

1h General Medicine

Louisiana State Board of Medical Examiners - Physicians & Surgeons

Physician & Surgeon

1h Category I CME

Mississippi State Board of Medical Licensure

Medical Doctor

1h AMA Category I

Physician Assistant

1h AMA Category I

State Medical Board of Ohio

Doctor of Medicine

1h AMA Category I